E-ISSN: 1308-5263
Tumor Lysis Syndrome Due to Targeting of Hepatocellular Carcinoma Associated with Chronic Myelomonocytic Leukemia [Turk J Hematol]
Turk J Hematol. 2019; 36(3): 218-219 | DOI: 10.4274/tjh.galenos.2019.2019.0113  

Tumor Lysis Syndrome Due to Targeting of Hepatocellular Carcinoma Associated with Chronic Myelomonocytic Leukemia

Müfide Okay1, Sıla Çetik2, İbrahim C. Haznedaroğlu1
1Hacettepe University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Ankara, Turkey
2Hacettepe University Faculty of Medicine, Department of Internal Medicine, Ankara, Turkey

Keywords: Leukemia, Myelomonocytic, Chronic, Tumor lysis syndrome, Hematologic neoplasms


Kronik Myelomonositik Lösemi ile İlişkili Hepatoselüler Karsinomun Hedefe Yönelik Tedavisine Bağlı Tümör Lizis Sendromu

Müfide Okay1, Sıla Çetik2, İbrahim C. Haznedaroğlu1
1Hacettepe University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Ankara, Turkey
2Hacettepe University Faculty of Medicine, Department of Internal Medicine, Ankara, Turkey

Anahtar Kelimeler: Lösemi, Myelomonositik, Kronik, Tümör lizis sendromu, Hematolojik neoplaziler


Müfide Okay, Sıla Çetik, İbrahim C. Haznedaroğlu. Tumor Lysis Syndrome Due to Targeting of Hepatocellular Carcinoma Associated with Chronic Myelomonocytic Leukemia. Turk J Hematol. 2019; 36(3): 218-219

Corresponding Author: Müfide Okay, Türkiye


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar


 



Impact Factor (2018) = 0.779